| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
56,269 |
53,563 |
$5.03M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,221 |
23,410 |
$2.56M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,801 |
1,731 |
$135K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
803 |
800 |
$118K |
| 99050 |
|
6,339 |
6,220 |
$96K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
994 |
913 |
$94K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,464 |
2,384 |
$74K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,438 |
2,358 |
$73K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,017 |
959 |
$57K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,799 |
1,729 |
$45K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,849 |
1,778 |
$43K |
| 99215 |
Prolong outpt/office vis |
357 |
355 |
$41K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
201 |
200 |
$26K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,023 |
2,002 |
$25K |
| 81025 |
|
2,492 |
2,412 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
377 |
377 |
$16K |
| 87210 |
|
3,312 |
3,181 |
$15K |
| 87220 |
|
3,273 |
3,145 |
$13K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
507 |
504 |
$11K |
| 99051 |
|
2,514 |
2,497 |
$10K |
| 86485 |
|
327 |
323 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
879 |
874 |
$7K |
| 80053 |
Comprehensive metabolic panel |
629 |
625 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,487 |
1,455 |
$6K |
| 81003 |
|
2,591 |
2,535 |
$5K |
| 86780 |
|
376 |
375 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,299 |
2,247 |
$3K |
| 90658 |
|
106 |
106 |
$3K |
| 81001 |
|
943 |
931 |
$3K |
| 86803 |
|
211 |
211 |
$3K |
| 82962 |
|
1,025 |
981 |
$3K |
| T1015 |
Clinic visit/encounter, all-inclusive |
235 |
235 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
77 |
77 |
$1K |
| 82948 |
|
239 |
233 |
$1K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
552 |
534 |
$587.54 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
63 |
63 |
$560.55 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
162 |
158 |
$364.93 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12 |
12 |
$84.74 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12 |
12 |
$81.69 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
26 |
26 |
$1.98 |
| A9150 |
Non-prescription drugs |
123 |
123 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
29 |
29 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
87 |
87 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
13 |
13 |
$0.00 |